Continuous glucose monitoring in type 2 diabetes: Overcoming barriers to optimize outcomes
51:31
Insights from EHA and ISTH 2024: How can we optimize care for patients with chronic ITP?
55:13
Precision targeting of MET in NSCLC: A multidisciplinary approach
33:48
Primary biliary cholangitis: Appraising the changing therapeutic landscape
39:00
Treating moderate-to-severe atopic dermatitis in children and adolescents: Insights from the experts
40:23
Belantamab mafodotin combination therapies in early RRMM
39:16
Where to next in limited-stage small cell lung cancer? The role of immune checkpoint inhibitors
38:00
Navigating the management of cholestatic pruritus in patients with PBC
40:57